STOCK TITAN

Allarity Therapeutics, Inc. (ALLR) Net Income by Year

ALLR

Allarity Therapeutics, Inc. reported a net loss of $11.2M in fiscal year 2025. This represents an increase of 54.2% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Allarity Therapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income -$11.2M
YoY +54.2%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ALLR Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Net Income-$11.2M+54.2%-$24.5M-106.0%-$11.9M+25.9%-$16.1M+39.7%-$26.6M-302.7%-$6.6M

ALLR Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$3.4M-46.8%-$2.8M-0.7%N/A-$2.8M+75.8%-$2.3M-42.4%-$2.7M+28.9%N/A-$11.6M-160.6%-$1.6M+31.6%-$3.8M-14.6%N/A-$4.4M+11.7%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Allarity Therapeutics, Inc. financials

Frequently Asked Questions

What was Allarity Therapeutics, Inc.'s net income in fiscal year 2025?

Allarity Therapeutics, Inc. reported a net loss of $11.2M in fiscal year 2025.

How fast is Allarity Therapeutics, Inc.'s net income growing?

Allarity Therapeutics, Inc. (ALLR) net income rose by 54.2% year over year, from -$24.5M to -$11.2M in fiscal year 2025.

How has Allarity Therapeutics, Inc.'s net income changed over the years?

Across the 6 fiscal years this page covers, Allarity Therapeutics, Inc. (ALLR) net income went from -$6.6M in fiscal year 2020 to -$11.2M in fiscal year 2025.

Allarity Therapeutics, Inc. (ALLR) reported -$3.4M in net income in Q2 2026. This represents a decrease of 46.8% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Allarity Therapeutics, Inc. (ALLR) reported on that line in every period on record.